SMTL ID : 4e1z.1

Structure of mouse Tyk-2 complexed to a 3-aminoindazole inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.50 Å

Oligo State

monomer

Ligands

1 x 0MX: N-[5-(4-{[(3-chlorophenyl)sulfonyl]amino}phenyl)-1H-indazol-3-yl]furan-2-carboxamide(Non-covalent)

0MX.1: 21 residues within 4Å: Chain A: R.15, L.17, G.18, E.19, G.20, G.23, K.24, V.25, A.42, K.44, E.93, Y.94, V.95, P.96, L.97, G.98, R.141, N.142, L.144, G.154, D.155 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:V.25, A:A.42, A:L.144, A:L.144, A:D.155 Hydrogen bonds: A:E.19, A:E.93, A:V.95, A:V.95, A:R.141, A:R.141 Water bridges: A:R.101, A:R.101 pi-Cation interactions: A:R.15

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Argiriadi, M.A. et al., Enabling structure-based drug design of Tyk2 through co-crystallization with a stabilizing aminoindazole inhibitor. Bmc Struct.Biol. (2012)

Release Date

2012-10-03

Peptides

Non-receptor tyrosine-protein kinase TYK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Non-receptor tyrosine-protein kinase TYK2